Assessing the Pharma-Biotech Sector with Bloomberg Intelligence Data
With guidance from Bloomberg analysts, you'll learn to forecast drug sales by exporting prescription data into excel and use the catalyst calendar to plot future drug-related events.
Together, we’ll explore how to access healthcare policies, litigation research, consensus forecasts and licensing deal data. You’ll also find out about future live events and webinars, organized by Bloomberg Intelligence, to further support your learning in this field. Discussion topics: - Symphony health prescription data
- Bloomberg Intelligence drug catalyst calendar
- Bloomberg Intelligence pharma-biotech licensing data
- BI healthcare policy research
- BI healthcare events and webinar
Speakers
Michael Shah
Healthcare Analyst
Bloomberg Intelligence
Michael Shah graduated from the London School of Economics with a BSc in Accounting and Finance. He has been focused on the healthcare sector for the past ten years, initially assisting with U.S and European Large Pharmaceuticals coverage before transitioning to Biotech.
Grace Guo
Industry Analyst for Biotech and Pharma
Bloomberg Intelligence
Grace Guo is an industry analyst for biotech and pharmaceuticals at Bloomberg Intelligence, a unique research platform that provides context on industries, companies, government policy, litigation and the economy, available on the Bloomberg Professional Service at BI GO. Ms. Guo specializes in researching expected timelines of upcoming regulatory and clinical milestones of pipeline drugs in development. She is responsible for of the BI Biotech-Pharma Catalyst Calendar, which covers hundreds of publicly traded biotech and pharma companies and is published weekly on the Bloomberg terminal since 2011.
Roger Thomson
Regional Marketing Analyst, Bloomberg Intelligence
Bloomberg
Roger Thomson is the Regional Marketing Analyst for Bloomberg Intelligence in EMEA. Prior to joining Bloomberg in May 2020, he held senior institutional sales roles with UBS and Morgan Stanley, for over 20 years. Prior to that he worked as a portfolio manager, covering U.S. Equities at Edinburgh Fund Managers. He has built and maintains excellent senior client relationships with leading asset managers. He is a CFA Charterholder.